PARATEK PHARMACEUTICALS INC shareholders Q2 2023

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 68 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 5.22 and the average weighting 0.1%.

PARATEK PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Bruce & Co., Inc. 1,556,247$3,439,3050.96%
NEXPOINT ASSET MANAGEMENT, L.P. 2,495,770$5,515,6520.80%
CM Management, LLC 250,000$5530.54%
Newtyn Management, LLC 764,274$1,689,0460.40%
GENERAL AMERICAN INVESTORS CO INC 1,839,424$4,065,1270.35%
Trellus Management Company, LLC 127,000$280,6700.35%
Hunting Hill Global Capital, LLC 361,226$798,3090.26%
Eversept Partners, LP 1,327,857$2,934,5640.24%
PenderFund Capital Management Ltd. 233,590$6840.21%
FIFTH LANE CAPITAL, LP 261,781$578,5360.17%
Deuterium Capital Management, LLC 110,272$243,7020.16%
GABELLI & Co INVESTMENT ADVISERS, INC. 306,950$678,3600.11%
Rock Springs Capital Management LP 1,734,037$3,832,2220.09%
Carlyle Group Inc. 1,041,131$2,300,9000.08%
EQUITEC PROPRIETARY MARKETS, LLC 97,700$215,9170.06%
EQUITEC PROPRIETARY MARKETS, LLC 95,600$211,2760.06%
J. Goldman & Co LP 758,431$1,676,1330.06%
Yakira Capital Management, Inc. 100,000$221,0000.06%
Alpine Global Management, LLC 66,402$146,7480.04%
DELTEC ASSET MANAGEMENT LLC 70,468$155,7340.03%
External links

This page lists PARATEK PHARMACEUTICALS INC's shareholders in Q2 2023. To view PARATEK PHARMACEUTICALS INC's shareholder history, click here.